跳至主要内容
临床试验/NCT01089907
NCT01089907Unknown不适用

Genomics Evolution in Childhood Acute Lymphoblastic Leukemia

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
试验地点
1

研究概览

简要总结

To study the genomics with cell cycle and lymphocyte differentiation in disease, remission and relapse of childhood acute lymphoblastic leukemia. Then correlate these data with age, white cell count, cytogenetic changes, response to the chemotherapy and prognosis.

详细描述

In order to know the genomic evolution of childhood acute lymphoblastic leukemia, we will collect bone marrow (10c.c.) at diagnosis, remission and relapse. We will do the following genes in addition to gene-chip including IKZF1,ETV6, EBF1, NR3C1, RAG1/G2, TCF3, BTLA, PAX5,LEF1, ERG and VPREB1.We will study the gene dosages and degree of methylation. The estimated patients numbers will be 300-400. Then we will correlate these data with patients'age, white blood cell count at diagnosis, cytogenetic abnormalities, response to the chemotherapy and prognosis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
1 Day 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed as acute lymphoblastic leukemia
  • age less than or equal to 18 years old
  • signed informed consent

排除标准

  • who is not acute lymphoblastic leukemia
  • who did not sign informed consent

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验